Status:
RECRUITING
Topical Imiquimod Treatment of Oral Dysplasia
Lead Sponsor:
University of Southern California
Conditions:
Oral Dysplasia
Leukoplakia Oral
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The goal of this clinical trial is to determine the effectiveness of imiquimod in treating oral dysplasia in adult patients. Imiquimod 5% cream could be a safe and practical treatment for oral epithel...
Eligibility Criteria
Inclusion
- The patient has a biopsy-proven diagnosis of oral epithelial dysplasia.
- The patient is ineligible for or unwilling to undergo surgical or laser therapy.
- The patient is over 18 years old.
- The patient agrees to join the study and completes the informed consent process.
Exclusion
- The patient has OL, and excisional surgical removal is indicated.
- The patient is immunocompromised.
- The patient is under 18 years old.
- The patient refused to join the study or did not complete the informed consent process.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07210775
Start Date
October 1 2025
End Date
October 1 2027
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OralCare PreCancer and Pain Clinic
Los Angeles, California, United States, 90089